72 related articles for article (PubMed ID: 9875585)
1. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy.
Miralles P; Berenguer J; García de Viedma D; Padilla B; Cosin J; López-Bernaldo de Quirós JC; Muñoz L; Moreno S; Bouza E
AIDS; 1998 Dec; 12(18):2467-72. PubMed ID: 9875585
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune Suppression.
McEntire CRS; Fletcher A; Toledano M; Epstein S; White E; Tan CS; Mao-Draayer Y; Banks SA; Aksamit AJ; Gelfand JM; Thakur KT; Anand P; Cortese I; Bhattacharyya S
JAMA Neurol; 2023 Jun; 80(6):624-633. PubMed ID: 37093609
[TBL] [Abstract][Full Text] [Related]
3. Brain computed tomography of patients with HIV/AIDS before the advent of subsidized treatment program in Nigeria.
Eze KC; Eze EU
Niger Med J; 2012 Oct; 53(4):231-5. PubMed ID: 23661884
[TBL] [Abstract][Full Text] [Related]
4. TLR3 agonism re-establishes CNS immune competence during
Hussain RZ; Cravens PC; Doelger R; Dentel B; Herndon E; Loof N; Tsai P; Okuda DT; Racke MK; Stüve O
Ann Clin Transl Neurol; 2018 Dec; 5(12):1543-1561. PubMed ID: 30564621
[TBL] [Abstract][Full Text] [Related]
5. Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells.
Sariyer IK; Sariyer R; Otte J; Gordon J
PLoS One; 2016; 11(6):e0156819. PubMed ID: 27257867
[TBL] [Abstract][Full Text] [Related]
6. Immune surveillance and response to JC virus infection and PML.
Beltrami S; Gordon J
J Neurovirol; 2014 Apr; 20(2):137-49. PubMed ID: 24297501
[TBL] [Abstract][Full Text] [Related]
7. Neurological complications in HIV.
Hogan C; Wilkins E
Clin Med (Lond); 2011 Dec; 11(6):571-5. PubMed ID: 22268312
[TBL] [Abstract][Full Text] [Related]
8. The immune reconstitution inflammatory syndrome related to HIV co-infections: a review.
Huis in 't Veld D; Sun HY; Hung CC; Colebunders R
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):919-27. PubMed ID: 21964588
[TBL] [Abstract][Full Text] [Related]
9. Unmasking of PML by HAART: unusual clinical features and the role of IRIS.
Sidhu N; McCutchan JA
J Neuroimmunol; 2010 Feb; 219(1-2):100-4. PubMed ID: 19962769
[TBL] [Abstract][Full Text] [Related]
10. Immune reconstitution inflammatory syndrome after initiating highly active antiretroviral therapy in HIV-infected children.
Kilborn T; Zampoli M
Pediatr Radiol; 2009 Jun; 39(6):569-74. PubMed ID: 19277634
[TBL] [Abstract][Full Text] [Related]
11. Natalizumab and progressive multifocal leucoencephalopathy.
Berger JR
Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii48-53. PubMed ID: 17038473
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.
Miller CS; Berger JR; Mootoor Y; Avdiushko SA; Zhu H; Kryscio RJ
J Clin Microbiol; 2006 Jul; 44(7):2409-15. PubMed ID: 16825357
[TBL] [Abstract][Full Text] [Related]
13. AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.
Roberts MT
CNS Drugs; 2005; 19(8):671-82. PubMed ID: 16097849
[TBL] [Abstract][Full Text] [Related]
14. Opportunistic infections of the CNS in patients with AIDS: diagnosis and management.
Collazos J
CNS Drugs; 2003; 17(12):869-87. PubMed ID: 12962527
[TBL] [Abstract][Full Text] [Related]
15. Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
Haas DW; Johnson B; Nicotera J; Bailey VL; Harris VL; Bowles FB; Raffanti S; Schranz J; Finn TS; Saah AJ; Stone J
Antimicrob Agents Chemother; 2003 Jul; 47(7):2131-7. PubMed ID: 12821458
[TBL] [Abstract][Full Text] [Related]
16. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).
Antinori A; Cingolani A; Lorenzini P; Giancola ML; Uccella I; Bossolasco S; Grisetti S; Moretti F; Vigo B; Bongiovanni M; Del Grosso B; Arcidiacono MI; Fibbia GC; Mena M; Finazzi MG; Guaraldi G; Ammassari A; d'Arminio Monforte A; Cinque P; De Luca A;
J Neurovirol; 2003; 9 Suppl 1():47-53. PubMed ID: 12709872
[TBL] [Abstract][Full Text] [Related]
17. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.
Ferrante P; Delbue S; Pagani E; Mancuso R; Marzocchetti A; Borghi E; Maserati R; Bestetti A; Cinque P
J Neurovirol; 2003; 9 Suppl 1():42-6. PubMed ID: 12709871
[TBL] [Abstract][Full Text] [Related]
18. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.
Seth P; Diaz F; Major EO
J Neurovirol; 2003 Apr; 9(2):236-46. PubMed ID: 12707854
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system.
Cinque P; Bossolasco S; Lundkvist A
J Clin Virol; 2003 Jan; 26(1):1-28. PubMed ID: 12589831
[TBL] [Abstract][Full Text] [Related]
20. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.
Gasnault J; Kousignian P; Kahraman M; Rahoiljaon J; Matheron S; Delfraissy JF; Taoufik Y
J Neurovirol; 2001 Aug; 7(4):375-81. PubMed ID: 11517420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
